Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01047865 · ClinicalTrials.gov registry record
Type 1 Diabetes Recurrence in Pancreas Transplants
A clinical trial of Diabetes Mellitus, Type 1, sponsored by University of Miami.
- Recruiting
- Registry status
- 400
- Enrollment target
- 1
- Study location
NCT01047865: Recruiting study of Diabetes Mellitus, Type 1, sponsored by University of Miami.
NCT01047865 is a study of Diabetes Mellitus, Type 1 that is actively recruiting participants, run by University of Miami. The registered enrollment target is 400 participants, below the 1,263-participant average among 118 other Diabetes Mellitus, Type 1 trials with a reported enrollment target (68% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01047865, a study of Diabetes Mellitus, Type 1, is actively recruiting participants, sponsored by University of Miami.
- RECRUITING
- Registry status
- 400 participants
- Enrollment target
- 1
- Study location
Study Summary
The hypothesis is that humoral and cellular islet-specific responses are an early risk factor for recurrence of autoimmunity and hyperglycemia in simultaneous pancreas-kidney (SPK) recipients independent of alloimmunity. This study will test the hypothesis and will assess their individual and combined predictive value.
Primary Outcome
Antibody recurrence
Conditions Studied
Study Locations (1)
Florida
- University of Miami Miller School of Medicine Transplant Clinic - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2005-05 |
| Est. Completion | 2026-05 |
What NCT01047865 shows while recruiting
NCT01047865 is an observational study that tracks outcomes without assigning an intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, below the 1,263-participant average among 118 other Diabetes Mellitus, Type 1 trials with a reported enrollment target (68% lower).
The record links to 1 condition, with Diabetes Mellitus, Type 1 appearing as the primary indexed condition, and to 0 interventions.
NCT01047865 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT01047865 about?
NCT01047865 is a clinical study titled "Type 1 Diabetes Recurrence in Pancreas Transplants". The hypothesis is that humoral and cellular islet-specific responses are an early risk factor for recurrence of autoimmunity and hyperglycemia in simultaneous pancreas-kidney (SPK) recipients independent of alloimmunity. This study will test the hypothesis and will assess their individual and combin...
What is the current status of trial NCT01047865?
This trial is currently recruiting. The enrollment target is 400 participants. The study started on 2005-05. Estimated completion is 2026-05.
What conditions does trial NCT01047865 study?
This clinical trial studies the following conditions: Diabetes Mellitus, Type 1.
Who is sponsoring clinical trial NCT01047865?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01047865 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus, Type 1
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01047865's enrollment target sits among peer trials
400 18th of 118 higher than 101 of 118 other Diabetes Mellitus, Type 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetes Mellitus, Type 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Continuous Glucose Metrics in Patients With Gastroparesis in Type 1 or Type 2 Diabetes
RECRUITING · NA
-
Subcutaneous Pharmacokinetic Evaluation of Monomeric Insulin and Lyumjev in Adults With Type 1 Diabetes
RECRUITING · Phase 1
-
Genetics Of Autoimmunity In Type I Diabetes
RECRUITING
-
Islet Transplantation in Type 1 Diabetic Kidney Allograft
RECRUITING · Phase 2
-
A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes Mellitus
RECRUITING · Phase 1
-
Regulation of Brain Glucose Metabolism in Type 1 Diabetes
RECRUITING · Early Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia